Cigna Group (NYSE:CI) Reaches New 52-Week High - Time to Buy?

Key Points

• Cigna shares reached a new 52-week high, trading as high as $311.98 and up about 3.5%, with a market capitalization of approximately $83.24 billion.
• Analysts remain generally positive, with a “Moderate Buy” consensus from 23 analysts and an average price target of $338.24; recent targets range from $310 to $370.
• Cigna exceeded quarterly expectations, reporting $7.78 in EPS versus $7.60 expected and $71.56 billion in revenue, up 6.7% year over year. However, insiders sold shares under pre-arranged Rule 10b5-1 plans, totaling about $6.3 million over three months.

Cigna Group (NYSE:CI - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Thursday. The company traded as high as $311.98 and last traded at $312.3050, with a volume of 294,103 shares trading hands. The stock had previously closed at $304.37.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on CI. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Barclays raised their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Piper Sandler set a $370.00 target price on shares of Cigna Group and gave the company an "overweight" rating in a research report on Friday, October 2nd. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cigna Group in a report on Thursday, August 27th. Finally, Guggenheim increased their price target on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $338.24.

Cigna Group Trading Up 3.5%

The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market capitalization of $83.24 billion, a PE ratio of 13.03, a PEG ratio of 1.03 and a beta of 0.29. The stock has a 50-day moving average price of $280.49 and a two-hundred day moving average price of $282.73.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The company had revenue of $71.56 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the company posted $7.20 EPS. The firm's revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts forecast that Cigna Group will post 30.50 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Everett Neville sold 617 shares of the company's stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the company's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company's stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 22,730 shares of company stock valued at $6,293,359. Corporate insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Cigna Group

Institutional investors and hedge funds have recently bought and sold shares of the business. Osbon Capital Management LLC bought a new position in shares of Cigna Group in the second quarter worth about $26,000. Cedar Mountain Advisors LLC raised its stake in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after purchasing an additional 68 shares during the period. Johnson Financial Group Inc. purchased a new position in Cigna Group in the 2nd quarter worth approximately $29,000. Fiduciary Financial Advisors purchased a new position in Cigna Group in the 2nd quarter worth approximately $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Cigna Group in the 2nd quarter worth approximately $34,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.